MRK:NYE-Merck & Company Inc. (new)

EQUITY | Drug Manufacturers | New York Stock Exchange

Last Closing Price

USD 76.72

Change

0.00 (0.00)%

Market Cap

USD 199.50B

Volume

0.01B

Average Target Price

USD 77.09 (0.48%)
Average Analyst Rating

Verdict

STA Verdict

Verdict

About

Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, and animal health.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2018-12-09 )

Largest Industry Peers for Drug Manufacturers

Symbol Name Price(Change) Market Cap
JNJ Johnson & Johnson

N/A

USD 390.04B
PFE Pfizer Inc.

N/A

USD 253.88B
NVS Novartis AG

N/A

USD 201.15B
ABBV AbbVie Inc.

N/A

USD 130.81B
LLY Eli Lilly and Company

N/A

USD 120.32B
SNY Sanofi American Depositary Sha..

N/A

USD 108.28B
AZN Astrazeneca PLC

N/A

USD 96.73B
GSK GlaxoSmithKline PLC

N/A

USD 92.53B
BMY Bristol-Myers Squibb Company

N/A

USD 86.64B
AGN Allergan plc

N/A

USD 51.41B

ETFs Containing MRK

IHE iShares U.S. Pharmaceutic.. 9.42 % 0.43 %

N/A

USD 0.40B
CNCR Loncar Cancer Immunothera.. 6.35 % 0.79 %

N/A

USD 0.04B
FTXH First Trust Nasdaq Pharma.. 6.24 % 0.60 %

N/A

USD 4.19M
PJP Invesco Dynamic Pharmaceu.. 6.02 % 0.57 %

N/A

USD 0.51B
PPH VanEck Vectors Pharmaceut.. 5.71 % 0.35 %

N/A

USD 0.26B
XLV SPDR Select Sector Fund -.. 5.68 % 0.14 %

N/A

USD 19.01B
IYH iShares U.S. Healthcare 5.40 % 0.43 %

N/A

USD 2.45B
HHL:CA Harvest Healthcare Leader.. 5.37 % 1.24 %

N/A

CAD 0.28B
HHL.U:CA Harvest Healthcare Leader.. 5.37 % 0.00 %

N/A

CAD 0.03B
LIFE:CA Evolve Global Healthcare .. 5.34 % 0.66 %

N/A

CAD 1.44M
LIFE.B:CA Evolve Global Healthcare .. 5.34 % 0.67 %

N/A

CAD 1.04M
XPH SPDR S&P Pharmaceuticals 5.06 % 0.35 %

N/A

USD 0.29B
FHLC Fidelity MSCI Health Care.. 4.95 % 0.08 %

N/A

USD 1.61B
VHT Vanguard Health Care 4.94 % 0.10 %

N/A

USD 8.82B
RXL ProShares Ultra Health Ca.. 4.56 % 0.95 %

N/A

USD 0.14B
PILL Direxion Daily Pharmaceut.. 4.52 % 0.00 %

N/A

USD 4.01M
DJD Invesco Dow Jones Industr.. 4.20 % 0.30 %

N/A

USD 0.05B
XHD:CA iShares U.S. High Dividen.. 4.12 % 0.33 %

N/A

CAD 0.20B
HDV iShares Core High Dividen.. 4.12 % 0.08 %

N/A

USD 6.57B
XHU:CA iShares U.S. High Dividen.. 4.12 % 0.32 %

N/A

CAD 0.03B
IXJ iShares Global Healthcare 4.07 % 0.47 %

N/A

USD 1.74B
JHMH John Hancock Multifactor .. 4.00 % 0.50 %

N/A

USD 0.06B
MTUM iShares Edge MSCI USA Mom.. 3.99 % 0.15 %

N/A

USD 3.60B
SDGA Impact Shares Sustainable.. 3.91 % 0.00 %

N/A

N/A
EDOW First Trust Dow 30 Equal .. 3.61 % 0.50 %

N/A

USD 0.06B
FDL First Trust Morningstar 3.60 % 0.45 %

N/A

USD 1.46B
ZWH.U:CA BMO US High Dividend Cove.. 3.50 % 0.72 %

N/A

CAD 0.06B
ZWH:CA BMO US High Dividend Cove.. 3.50 % 0.71 %

N/A

CAD 0.67B
USMC Principal U.S. Mega-Cap M.. 3.25 % 0.12 %

N/A

USD 1.50B
XDU:CA iShares Core MSCI US Qual.. 3.13 % 0.16 %

N/A

CAD 0.03B
HID:CA WisdomTree U.S. High Divi.. 2.75 % 0.41 %

N/A

CAD 0.01B
HID.B:CA WisdomTree U.S. High Divi.. 2.75 % 0.37 %

N/A

CAD 0.01B
DHS WisdomTree U.S. High Divi.. 2.74 % 0.38 %

N/A

USD 0.89B
YLDE ClearBridge Dividend Stra.. 2.64 % 0.59 %

N/A

N/A
FLQD Franklin LibertyQ Global .. 2.62 % 0.45 %

N/A

USD 0.02B
FLGD:CA Franklin LibertyQT Global.. 2.61 % 0.00 %

N/A

CAD 9.70M
VETS Pacer Military Times Best.. 2.57 % 0.60 %

N/A

USD 2.54M
SDOG ALPS Sector Dividend Dogs 2.47 % 0.40 %

N/A

USD 2.08B
XDG:CA iShares Core MSCI Global .. 2.35 % 0.22 %

N/A

CAD 0.07B
OUSA O'Shares FTSE U.S. Qualit.. 2.32 % 0.48 %

N/A

USD 0.58B
CCOR Cambria Core Equity 2.27 % 1.21 %

N/A

USD 0.08B
HEA.U:CA Horizons Enhanced Income .. 2.22 % 0.83 %

N/A

CAD 0.03B
UXM:CA First Asset Morningstar U.. 2.21 % 0.68 %

N/A

CAD 0.05B
UXM.B:CA First Asset Morningstar U.. 2.21 % 0.66 %

N/A

CAD 0.02B
FDRR Fidelity Dividend ETF for.. 2.18 % 0.29 %

N/A

USD 0.40B
RNDV First Trust US Equity Div.. 2.03 % 0.50 %

N/A

USD 5.15M
DGRO iShares Core Dividend Gro.. 2.00 % 0.08 %

N/A

USD 4.97B
PUD:CA Purpose US Dividend Fund 1.92 % 0.68 %

N/A

CAD 0.02B
PUD.B:CA Purpose US Dividend Fund 1.92 % 0.69 %

N/A

CAD 7.18M
PDF:CA Purpose Core Dividend Fun.. 1.87 % 0.68 %

N/A

CAD 0.32B
RYH Invesco S&P 500 Equal Wei.. 1.83 % 0.40 %

N/A

USD 0.70B
ZUH:CA BMO Equal Weight US Healt.. 1.79 % 0.39 %

N/A

CAD 0.39B
DSI iShares MSCI KLD 400 Soci.. 1.77 % 0.48 %

N/A

USD 1.18B
PDIV:CA Purpose Enhanced Dividend.. 1.77 % 0.00 %

N/A

CAD 0.01B
DTN WisdomTree U.S. Dividend .. 1.72 % 0.38 %

N/A

USD 0.77B
GURU Global X Guru Index 1.70 % 0.75 %

N/A

USD 0.05B
DVY iShares Select Dividend E.. 1.65 % 0.39 %

N/A

USD 16.76B
HUSV First Trust Exchange-Trad.. 1.64 % 0.70 %

N/A

USD 0.12B
RUD.U:CA RBC Quant U.S. Dividend L.. 1.56 % 0.43 %

N/A

CAD 0.03B
RUD:CA RBC Quant U.S. Dividend L.. 1.56 % 0.43 %

N/A

CAD 0.39B
ZDY.U:CA BMO US Dividend ETF 1.47 % 0.33 %

N/A

CAD 0.04B
ZDY:CA BMO US Dividend ETF 1.47 % 0.34 %

N/A

CAD 1.46B
FLLV Franklin Liberty U.S. Low.. 1.44 % 0.50 %

N/A

USD 0.01B
ZLU:CA BMO Low Volatility US Equ.. 1.40 % 0.33 %

N/A

CAD 0.72B
ZLU.U:CA BMO Low Volatility US Equ.. 1.40 % 0.33 %

N/A

CAD 0.03B
CHGX Change Finance U.S. Large.. 1.22 % 0.64 %

N/A

USD 3.83M
OEW Invesco S&P 100 Equal Wei.. 1.18 % 0.40 %

N/A

USD 3.24M
HONR InsightShares Patriotic E.. 1.12 % 0.00 %

N/A

N/A
DEF Invesco Defensive Equity 1.11 % 0.59 %

N/A

USD 0.19B
ACWV iShares Edge MSCI Min Vol.. 0.88 % 0.20 %

N/A

USD 3.64B
HERS.B:CA Evolve North American Gen.. 0.75 % 0.62 %

N/A

CAD 1.10M
HERS:CA Evolve North American Gen.. 0.75 % 0.62 %

N/A

CAD 2.57M
JDIV JPMorgan U.S. Dividend 0.69 % 0.00 %

N/A

N/A
JMIN JPMorgan U.S. Minimum Vol.. 0.66 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers)
Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 36.34% 100% A+ 97% A+
Dividend Return 2.56% 45% F 51% F
Total Return 38.90% 100% A+ 97% A+
Trailing 12 Months  
Capital Gain 38.06% 100% A+ 97% A+
Dividend Return 3.46% 64% D 58% F
Total Return 41.52% 100% A+ 97% A+
Trailing 5 Years  
Capital Gain 54.80% 83% B 85% B
Dividend Return 18.56% 67% D+ 59% F
Total Return 73.37% 83% B 86% B
Average Annual (5 Year Horizon)  
Capital Gain 3.42% 65% D 58% F
Dividend Return 6.59% 60% D- 54% F
Total Return 3.18% 73% C 59% F
Risk Return Profile  
Volatility (Standard Deviation) 13.42% 85% B 54% F
Risk Adjusted Return 49.14% 70% C- 53% F
Market Capitalization 167.96B 88% B+ 99% A+

Key Financial Ratios

  Ratio vs. Industry/Classification
(Drug Manufacturers)
Ratio vs. Market
(New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 60.89 24% F 8% F
Price/Book Ratio 6.27 21% F 10% F
Price / Cash Flow Ratio 4.57 25% F 25% F
Price/Free Cash Flow Ratio 23.04 32% F 23% F
Management Effectiveness  
Return on Equity 10.07% 56% F 56% F
Return on Invested Capital 16.00% 72% C- 75% C
Return on Assets 3.89% 52% F 60% D-
Debt to Equity Ratio 71.50% 46% F 51% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Higly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector